BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20809908)

  • 1. In vivo evaluation of photoreceptor mosaic in type 2 idiopathic macular telangiectasia using adaptive optics.
    Massamba N; Querques G; Lamory B; Querques L; Souied E; Soubrane G
    Acta Ophthalmol; 2011 Nov; 89(7):e601-3. PubMed ID: 20809908
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
    Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.
    Fallano KA; Ibrahim M; Nguyen QD; Do DV
    Can J Ophthalmol; 2010 Dec; 45(6):649-50. PubMed ID: 20648067
    [No Abstract]   [Full Text] [Related]  

  • 5. High-resolution retinal imaging of cone-rod dystrophy.
    Wolfing JI; Chung M; Carroll J; Roorda A; Williams DR
    Ophthalmology; 2006 Jun; 113(6):1019.e1. PubMed ID: 16650474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2.
    Nunes RP; Goldhardt R; de Amorim Garcia Filho CA; Thorell MR; Abbey AM; Kuriyan AE; Modi YS; Shah M; Yehoshua Z; Gregori G; Feuer W; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):162-70. PubMed ID: 25707040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2.
    Zhu M; Krilis M; Gillies MC
    Retina; 2013 Sep; 33(8):1547-50. PubMed ID: 23974952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusive idiopathic juxtafoveolar retinal telangiectasis type 4.
    Matonti F; Chazalon E; Hoffart L; Roux L; Denis D
    Can J Ophthalmol; 2013 Jun; 48(3):e45-7. PubMed ID: 23769792
    [No Abstract]   [Full Text] [Related]  

  • 10. Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry.
    Maruko I; Iida T; Sekiryu T; Fujiwara T
    Br J Ophthalmol; 2008 Nov; 92(11):1488-91. PubMed ID: 18703550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.
    Charbel Issa P; Finger RP; Kruse K; Baumüller S; Scholl HP; Holz FG
    Am J Ophthalmol; 2011 May; 151(5):876-886.e1. PubMed ID: 21334595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.
    Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A
    Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel clinical sign in macular telangiectasia type 2.
    Jindal A; Choudhury H; Pathengay A; Flynn HW
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):134-6. PubMed ID: 25559527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomographic angiography in type 1 idiopathic macular telangiectasia.
    Pappuru RR; Peguda HK; Dave VP
    Clin Exp Optom; 2018 Jan; 101(1):143-144. PubMed ID: 28295586
    [No Abstract]   [Full Text] [Related]  

  • 15. ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY.
    Scoles D; Flatter JA; Cooper RF; Langlo CS; Robison S; Neitz M; Weinberg DV; Pennesi ME; Han DP; Dubra A; Carroll J
    Retina; 2016 Jan; 36(1):91-103. PubMed ID: 26166796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoreceptor restoration in unilateral acute idiopathic maculopathy on adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Yoshimura N
    Arch Ophthalmol; 2011 Dec; 129(12):1633-5. PubMed ID: 22159690
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography.
    Park SJ; Woo SJ; Park KH; Hwang JM; Chung H
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3673-9. PubMed ID: 20164460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual function in patients with idiopathic macular telangiectasia type 1.
    Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Acta Ophthalmol; 2016 Nov; 94(7):e672-e673. PubMed ID: 27230481
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo evaluation of photoreceptor mosaic in early onset large colloid drusen using adaptive optics.
    Querques G; Massamba N; Guigui B; Lea Q; Lamory B; Soubrane G; Souied EH
    Acta Ophthalmol; 2012 Jun; 90(4):e327-8. PubMed ID: 21883987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.